Literature DB >> 23994214

Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.

Masahiro Ono1, Shuntaro Oka, Hiroyuki Okudaira, David M Schuster, Mark M Goodman, Keiichi Kawai, Yoshifumi Shirakami.   

Abstract

Positron emission tomography (PET) with amino acid tracers is useful for the visualization and assessment of therapeutic effects on gliomas. Our purpose is to elucidate the transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid (anti-[¹⁸F]FACBC) and L-[methyl-¹¹C]methionine ([¹¹C]Met) in normal human astrocytes (NHA), low-grade (Hs683, SW1088), and high-grade (U87MG, T98G) human glioma cell lines. Because the short half-lives of fluorine-18 and carbon-11 are inconvenient for in vitro experiments, trans-1-amino-3-fluoro[1-¹⁴C]cyclobutanecarboxylic acid (anti-[¹⁴C]FACBC) and L-[methyl-¹⁴C]methionine ([¹⁴C]Met) were used instead of the PET tracers. Time-course uptake experiments showed that uptake of anti-[¹⁴C]FACBC was 1.4-2.6 times higher than that of [¹⁴C]Met in NHA and low-grade glioma cells, and was almost equal to that of [¹⁴C]Met in high-grade glioma cells. To identify the amino acid transporters (AATs) involved in the transport of anti-[¹⁴C]FACBC and [¹⁴C]Met, we carried out competitive inhibition experiments using synthetic/naturally-occurring amino acids as inhibitors. We found that anti-[¹⁴C]FACBC uptake in the presence of Na⁺ was strongly inhibited by L-glutamine and L-serine (the substrates for ASC system AATs), whereas L-phenylalanine and 2-amino-bicyclo[2,2,1]heptane-2-carboxylic acid (BCH, the substrates for L system AATs) robustly inhibited Na⁺-independent anti-[¹⁴C]FACBC uptake. Regardless of Na⁺, [¹⁴C]Met uptake was inhibited strongly by L-phenylalanine and BCH. Moreover, the exchange transport activity of L-glutamine for anti-[¹⁴C]FACBC was stronger than that of BCH in the presence of Na⁺, whereas that for [¹⁴C]Met was almost equal to BCH. These results demonstrate that ASC and L are important transport systems for anti-[¹⁸F]FACBC uptake, while system L is predominantly involved in [¹¹C]Met transport in human astrocytes and glioma cells.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2-(methylamino)-isobutyric acid; 2-amino-bicyclo[2,2,1]heptane-2-carboxylic acid; AAT(s); ASCT2; Amino acid transporter; BCH; Glioma; LAT1; MeAIB; Methionine; N-ethylmaleimide; NEM; PET; [(11)C]Met; [(14)C]Met; amino acid transporter(s); anti-FACBC; anti-[(14)C]FACBC; anti-[(18)F]FACBC; l-[methyl-(11)C]methionine; l-[methyl-(14)C]methionine; positron emission tomography; trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid; trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid

Mesh:

Substances:

Year:  2013        PMID: 23994214     DOI: 10.1016/j.brainres.2013.08.037

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

1.  Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors.

Authors:  Ahlem Bouhlel; Dong Zhou; Aixiao Li; Liya Yuan; Keith M Rich; Jonathan McConathy
Journal:  J Med Chem       Date:  2015-05-04       Impact factor: 7.446

2.  Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients.

Authors:  Caroline Stokke; Jakob Nordberg Nørgaard; Hilde Feiring Phillips; Alexander Sherwani; Syed Nuruddin; James Connelly; Fredrik Schjesvold; Mona-Elisabeth Revheim
Journal:  Mol Imaging Biol       Date:  2022-05-02       Impact factor: 3.484

3.  Selective modification of fluciclovine (18F) transport in prostate carcinoma xenografts.

Authors:  F I Tade; W G Wiles; G Lu; B Bilir; O Akin-Akintayo; J S Lee; D Patil; W Yu; C Ormenisan Gherasim; B Fei; C S Moreno; A O Osunkoya; E J Teoh; S Oka; H Okudaira; M M Goodman; D M Schuster
Journal:  Amino Acids       Date:  2018-06-15       Impact factor: 3.520

4.  Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers.

Authors:  Caroline Papin-Michault; Christelle Bonnetaud; Maxime Dufour; Fabien Almairac; Mickael Coutts; Stéphanie Patouraux; Thierry Virolle; Jacques Darcourt; Fanny Burel-Vandenbos
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

5.  [18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.

Authors:  Bérengère Dadone-Montaudié; Damien Ambrosetti; Maxime Dufour; Jacques Darcourt; Fabien Almairac; John Coyne; Thierry Virolle; Olivier Humbert; Fanny Burel-Vandenbos
Journal:  PLoS One       Date:  2017-09-22       Impact factor: 3.240

6.  Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial.

Authors:  Toshihiko Wakabayashi; Toshihiko Iuchi; Naohiro Tsuyuguchi; Ryo Nishikawa; Yoshiki Arakawa; Takashi Sasayama; Keisuke Miyake; Tadashi Nariai; Yoshitaka Narita; Naoya Hashimoto; Osamu Okuda; Hiroshi Matsuda; Kazuo Kubota; Kimiteru Ito; Yoichi Nakazato; Kan Kubomura
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017

7.  18F-FACBC PET/MRI in the evaluation of human brain metastases: a case report.

Authors:  Knut Johannessen; Erik Magnus Berntsen; Håkon Johansen; Tora S Solheim; Anna Karlberg; Live Eikenes
Journal:  Eur J Hybrid Imaging       Date:  2021-04-13

8.  [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.

Authors:  Zehui Wu; Zhihao Zha; Genxun Li; Brian P Lieberman; Seok Rye Choi; Karl Ploessl; Hank F Kung
Journal:  Mol Pharm       Date:  2014-08-11       Impact factor: 4.939

Review 9.  Usefulness of positron emission tomographic studies for gliomas.

Authors:  Keisuke Miyake; Daisuke Ogawa; Masaki Okada; Tetsuhiro Hatakeyama; Takashi Tamiya
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-05-31       Impact factor: 1.742

Review 10.  Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring.

Authors:  Amarnath Challapalli; Eric O Aboagye
Journal:  Front Oncol       Date:  2016-02-29       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.